Comparison of different endocrine therapies in management of bone metastases from breast carcinoma.
作者信息
Smith I E, Macaulay V
出版信息
J R Soc Med. 1985;78 Suppl 9(Suppl 9):15-7.
Abstract
摘要
相似文献
1
Comparison of different endocrine therapies in management of bone metastases from breast carcinoma.不同内分泌疗法治疗乳腺癌骨转移的比较
J R Soc Med. 1985;78 Suppl 9(Suppl 9):15-7.
2
[Endocrine therapy in breast carcinoma].[乳腺癌的内分泌治疗]
Minerva Chir. 1988 Sep 30;43(18 Suppl):63-6.
3
4
[Hormones and tumor therapy: current clinical status and future developments in endocrine therapy of breast cancer].[激素与肿瘤治疗：乳腺癌内分泌治疗的当前临床现状与未来发展]
Wien Klin Wochenschr. 1982 Sep 17;94(17):463-9.
5
Endocrine manipulation in the treatment of breast cancer.乳腺癌治疗中的内分泌调控
Clin Obstet Gynecol. 1975 Jun;18(2):227-37. doi: 10.1097/00003081-197506000-00015.
6
[Hormone therapy and chemotherapy of cancer of the breast].
Schweiz Med Wochenschr. 1969 Sep;99(36):1287-96.
7
Hormonal management of advanced breast cancer.晚期乳腺癌的激素治疗
Br Med J. 1969 May 3;2(5652):293-7. doi: 10.1136/bmj.2.5652.293.
8
[Current status of hormonotherapy of metastatic cancer of the breast].[乳腺癌转移性癌的激素治疗现状]
Bull Cancer. 1989;76(1):65-73.
9
Endocrine treatment of breast cancer.乳腺癌的内分泌治疗
CA Cancer J Clin. 1976 May-Jun;26(3):165-73. doi: 10.3322/canjclin.26.3.165.
10
Management of breast cancer.乳腺癌的管理
Clin Pharm. 1982 Nov-Dec;1(6):515-29.
引用本文的文献
1
Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.他莫昔芬：对其药效学、药代动力学特性及治疗用途的重新评估
Drugs. 1989 Apr;37(4):451-90. doi: 10.2165/00003495-198937040-00004.
2
Treating bony metastases.治疗骨转移瘤。
BMJ. 1991 Aug 24;303(6800):429-30. doi: 10.1136/bmj.303.6800.429.
本文引用的文献
1
HORMONAL THERAPY OF METASTATIC FEMALE BREAST CARCINOMA. V. PHENOL,4,4'-(DL-1,2-DIETHYL-ETHYLENE)DI- AND ANDROST-4-EN-3-ONE, 9-CHLORO-11-BETA, 17-BETA-DIHYDROXY-17-METHYL-.转移性女性乳腺癌的激素治疗。V. 苯酚，4,4'-（DL-1,2-二乙基乙烯）二-和雄甾-4-烯-3-酮，9-氯-11-β，17-β-二羟基-17-甲基-
Cancer. 1965 Apr;18:447-9. doi: 10.1002/1097-0142(196504)18:4<447::aid-cncr2820180408>3.0.co;2-6.
2
Hormonal treatment of disseminated cancer of the female breast.女性乳腺癌播散性癌的激素治疗。
Calif Med. 1963 Apr;98(4):189-94.
3
A comparative evaluation of adrenalectomy and cortisone in the treatment of advanced mammary carcinoma.肾上腺切除术与可的松治疗晚期乳腺癌的比较评估
Cancer. 1961 Nov-Dec;14:1259-65. doi: 10.1002/1097-0142(196111/12)14:6<1259::aid-cncr2820140616>3.0.co;2-4.
4
Results of hypophysectomy in the treatment of metastatic mammary carcinoma.垂体切除术治疗转移性乳腺癌的结果。
Cancer. 1959 Jan-Feb;12(1):85-92. doi: 10.1002/1097-0142(195901/02)12:1<85::aid-cncr2820120114>3.0.co;2-g.
5
Cortisone-thyroid therapy of metastatic mammary cancer.转移性乳腺癌的可的松-甲状腺素疗法
Ann Intern Med. 1957 Mar;46(3):457-84. doi: 10.7326/0003-4819-46-3-457.
6
Progestin therapy in advanced breast cancer: megestrol acetate--an evaluation of 160 treated cases.晚期乳腺癌的孕激素治疗：醋酸甲地孕酮——160例治疗病例的评估
Cancer. 1980 Dec 1;46(11):2369-72. doi: 10.1002/1097-0142(19801201)46:11<2369::aid-cncr2820461111>3.0.co;2-3.
7
Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposure.晚期乳腺癌女性两项临床试验的进展报告。试验I：他莫昔芬对比他莫昔芬加氨鲁米特。试验II：曾接受他莫昔芬治疗患者使用氨鲁米特。
Cancer Res. 1982 Aug;42(8 Suppl):3461s-3467s.
8
Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.氨鲁米特与他莫昔芬治疗转移性乳腺癌的随机试验。
Cancer Res. 1982 Aug;42(8 Suppl):3434s-3436s.
9
A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer.一项比较手术切除肾上腺与氨鲁米特加氢化可的松治疗晚期乳腺癌女性疗效的随机试验。
N Engl J Med. 1981 Sep 3;305(10):545-51. doi: 10.1056/NEJM198109033051003.
10
Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.他莫昔芬与氨鲁米特治疗晚期乳腺癌的随机交叉试验
Br Med J (Clin Res Ed). 1981 Nov 28;283(6304):1432-4. doi: 10.1136/bmj.283.6304.1432.
Zotero 插件